Fecal microbiota transplantation: in perspective - PubMed (original) (raw)

Review

Fecal microbiota transplantation: in perspective

Shaan Gupta et al. Therap Adv Gastroenterol. 2016 Mar.

Abstract

There has been increasing interest in understanding the role of the human gut microbiome to elucidate the therapeutic potential of its manipulation. Fecal microbiota transplantation (FMT) is the administration of a solution of fecal matter from a donor into the intestinal tract of a recipient in order to directly change the recipient's gut microbial composition and confer a health benefit. FMT has been used to successfully treat recurrent Clostridium difficile infection. There are preliminary indications to suggest that it may also carry therapeutic potential for other conditions such as inflammatory bowel disease, obesity, metabolic syndrome, and functional gastrointestinal disorders.

Keywords: Clostridium difficile infection; bacteriotherapy; fecal microbiota transplantation; gut microbiome; inflammatory bowel disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Figures

Figure 1.

Figure 1.

(a), (b) Schematic to indicate the events that contribute to Clostridium difficile infection: (a) the contributions of the pathogen to disease driven by reduced gut microbiota diversity; (b) how these contributions are minimized when a more diverse microbiota is present. (c), (d) Schematic to indicate the events that contribute to the proliferation of pathobionts (resident bacteria that can contribute to disease pathology under the appropriate altered environmental conditions) in the gut microbiota. The potential contribution of the gut microbiota, and the reduction of diversity in the microbiota in particular, is highlighted as a driver for disease to draw a comparison against C. difficile infection, using C. difficile infection as a model for disease caused by reduction in host gut-microbiota diversity.

Similar articles

Cited by

References

    1. Alang N., Kelly C. (2015) Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2 DOI: 10.1093/ofid/ofv004. - DOI - PMC - PubMed
    1. Andrews P., Borody T., Shortis N. (1995) Bacteriotherapy for chronic constipation – long term follow up. Gastroenterology 108: A563.
    1. Angelberger S., Reinisch W., Makristathis A., Lichtenberger C., Dejaco C., Papay P., et al. (2013) Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 108: 1620–1630. - PubMed
    1. Bakken J., Borody T., Brandt L., Brill J., Demarco D., Franzos M., et al. (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9: 1044–1049. - PMC - PubMed
    1. Bartlett J., Gerding D. (2008) Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 46(Suppl. 1): S12–S18. - PubMed

Publication types

LinkOut - more resources